|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07H 19/10 | (2006.01) |
| A61K 31/7068 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3160978 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733497.0 |
| Date of filing the European patent application | 2015-06-25 | |
| (97) | Date of publication of the European application | 2017-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation | 2020-08-25 |
| (86) | Number | PCT/GB2015/051857 |
| Date | 2015-06-25 |
| (87) | Number | WO 2015/198058 |
| Date | 2015-12-30 |
| (30) | Number | Date | Country code |
| 201411253 | 2014-06-25 | GB | |
| 2050MU2014 | 2014-06-25 | IN |
| (72) |
GRIFFITH, Hugh, GB
MCGUIGAN, Christopher, GB
SLUSARCZYK, Magdalena, GB
SERPI, Michaela, GB
FERRARI, Valentina, GB
|
| (73) |
NuCana plc,
3 Lochside Way, Edinburgh EH12 9DT,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gemcitabino provaistai |
| GEMCITABINE PRODRUGS |
| Payment date | Validity (years) | Amount | |
| 2023-05-26 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-06-25 |